Document is current
Any future updates will be listed below
-
Authors
Holz, Nathalie E. https://orcid.org/0000-0002-6225-9267
Zabihi, Mariam https://orcid.org/0000-0002-7083-2318
Kia, Seyed Mostafa https://orcid.org/0000-0002-7128-814X
Monninger, Maximillian
Aggensteiner, Pascal-M.
Siehl, Sebastian https://orcid.org/0000-0002-8933-7552
Floris, Dorothea L.
Bokde, Arun L. W. https://orcid.org/0000-0003-0114-4914
Desrivières, Sylvane https://orcid.org/0000-0002-9120-7060
Flor, Herta https://orcid.org/0000-0003-4809-5398
Grigis, Antoine
Garavan, Hugh
Gowland, Penny https://orcid.org/0000-0002-4900-4817
Heinz, Andreas https://orcid.org/0000-0001-5405-9065
Brühl, Rüdiger https://orcid.org/0000-0003-0111-5996
Martinot, Jean-Luc
Martinot, Marie-Laure Paillère https://orcid.org/0000-0002-0452-2450
Orfanos, Dimitri Papadopoulos https://orcid.org/0000-0002-1242-8990
Paus, Tomáš
Poustka, Luise
Fröhner, Juliane H. https://orcid.org/0000-0002-8493-6396
Smolka, Michael N. https://orcid.org/0000-0001-5398-5569
Vaidya, Nilakshi
Walter, Henrik https://orcid.org/0000-0002-9403-6121
Whelan, Robert https://orcid.org/0000-0002-2790-7281
Schumann, Gunter https://orcid.org/0000-0002-7740-6469
Meyer-Lindenberg, Andreas https://orcid.org/0000-0001-5619-1123
Brandeis, Daniel
Buitelaar, Jan K. https://orcid.org/0000-0001-8288-7757
Nees, Frauke
Beckmann, Christian
,
Martinot, Jean-Luc
Paillère Martinot, Marie-Laure
Fröhner, Juliane H.
Smolka, Michael N.
Walter, Henrik
Banaschewski, Tobias
Marquand, Andre F.
- License Information
-
More Information
Article History
Received: 30 August 2022
Accepted: 17 July 2023
First Online: 21 August 2023
Competing interests
: T.B. served in an advisory or consultancy role for eye level, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche and Takeda. He received conference support or speaker’s fee from Janssen, Medice and Takeda. L.P. served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fee from Shire. She received royalties from Hogrefe, Kohlhammer and Schattauer. C.F.B. is cofounder and director of SBGneuro. The present work is unrelated to the above grants and relationships. The other authors report no potential conflicts of interest.
